379 related articles for article (PubMed ID: 23175466)
21. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
22. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1.
Jeliazkova P; Jörs S; Lee M; Zimber-Strobl U; Ferrer J; Schmid RM; Siveke JT; Geisler F
Hepatology; 2013 Jun; 57(6):2469-79. PubMed ID: 23315998
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.
Walesky C; Edwards G; Borude P; Gunewardena S; O'Neil M; Yoo B; Apte U
Hepatology; 2013 Jun; 57(6):2480-90. PubMed ID: 23315968
[TBL] [Abstract][Full Text] [Related]
24. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
25. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
26. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
27. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
Liu Y; Zhuo S; Zhou Y; Ma L; Sun Z; Wu X; Wang XW; Gao B; Yang Y
J Hepatol; 2022 Mar; 76(3):652-664. PubMed ID: 34793870
[TBL] [Abstract][Full Text] [Related]
28. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.
Kowalik MA; Saliba C; Pibiri M; Perra A; Ledda-Columbano GM; Sarotto I; Ghiso E; Giordano S; Columbano A
Hepatology; 2011 Jun; 53(6):2086-96. PubMed ID: 21391223
[TBL] [Abstract][Full Text] [Related]
29. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.
Morell CM; Fiorotto R; Fabris L; Strazzabosco M
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):447-54. PubMed ID: 23806629
[TBL] [Abstract][Full Text] [Related]
30. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
[TBL] [Abstract][Full Text] [Related]
31. Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice.
Heindryckx F; Kuchnio A; Casteleyn C; Coulon S; Olievier K; Colle I; Geerts A; Libbrecht L; Carmeliet P; Van Vlierberghe H
J Hepatol; 2012 Jul; 57(1):61-8. PubMed ID: 22420978
[TBL] [Abstract][Full Text] [Related]
32. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
33. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
Rohr-Udilova N; Sieghart W; Eferl R; Stoiber D; Björkhem-Bergman L; Eriksson LC; Stolze K; Hayden H; Keppler B; Sagmeister S; Grasl-Kraupp B; Schulte-Hermann R; Peck-Radosavljevic M
Hepatology; 2012 Apr; 55(4):1112-21. PubMed ID: 22105228
[TBL] [Abstract][Full Text] [Related]
34. Hepatic Notch2 deficiency leads to bile duct agenesis perinatally and secondary bile duct formation after weaning.
Falix FA; Weeda VB; Labruyere WT; Poncy A; de Waart DR; Hakvoort TB; Lemaigre F; Gaemers IC; Aronson DC; Lamers WH
Dev Biol; 2014 Dec; 396(2):201-13. PubMed ID: 25446530
[TBL] [Abstract][Full Text] [Related]
35. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice.
Teoh NC; Dan YY; Swisshelm K; Lehman S; Wright JH; Haque J; Gu Y; Fausto N
Hepatology; 2008 Jun; 47(6):2078-88. PubMed ID: 18506893
[TBL] [Abstract][Full Text] [Related]
36. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
[TBL] [Abstract][Full Text] [Related]
37. Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.
Duong FH; Dill MT; Matter MS; Makowska Z; Calabrese D; Dietsche T; Ketterer S; Terracciano L; Heim MH
Carcinogenesis; 2014 Jan; 35(1):114-22. PubMed ID: 23901063
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats.
Bralet MP; Pichard V; Ferry N
Hepatology; 2002 Sep; 36(3):623-30. PubMed ID: 12198654
[TBL] [Abstract][Full Text] [Related]
39. Hepatic tumors induced by sex steroids.
Mays ET; Christopherson W
Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]